Arbutus Biopharma Corp [ABUS] gain 16.80% so far this year. What now?
Arbutus Biopharma Corp [NASDAQ: ABUS] traded at a high on Wednesday, posting a 15.87 gain after which it closed the day’ session at $2.92. The company report on March 8, 2024 at 7:30 AM that Arbutus to Participate in Two Upcoming Investor Conferences. Arbutus Biopharma